Total Payments
$56,629
2024 Payments
$1,557
Companies
30
Transactions
190
Medicare Patients
5,969
Medicare Billing
$455,049
Payment Breakdown by Category
Other$39,136 (69.1%)
Food & Beverage$10,096 (17.8%)
Travel$7,045 (12.4%)
Education$352.26 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39,136 | 20 | 69.1% |
| Food and Beverage | $10,096 | 132 | 17.8% |
| Travel and Lodging | $7,045 | 25 | 12.4% |
| Education | $352.26 | 13 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| United Therapeutics Corporation | $27,361 | 53 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $17,460 | 21 | $0 (2024) |
| Abbott Laboratories | $4,502 | 35 | $0 (2024) |
| HEARTFLOW, INC. | $1,701 | 12 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,144 | 17 | $0 (2024) |
| CVRx, Inc. | $632.78 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $532.27 | 6 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $443.49 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $375.00 | 3 | $0 (2019) |
| Amgen Inc. | $225.45 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,557 | 23 | United Therapeutics Corporation ($225.76) |
| 2023 | $4,592 | 35 | HeartFlow, Inc. ($1,681) |
| 2022 | $10,838 | 26 | United Therapeutics Corporation ($6,700) |
| 2021 | $5,739 | 9 | United Therapeutics Corporation ($2,713) |
| 2020 | $6,347 | 12 | United Therapeutics Corporation ($4,125) |
| 2019 | $22,239 | 33 | United Therapeutics Corporation ($13,228) |
| 2018 | $2,555 | 25 | Abbott Laboratories ($1,708) |
| 2017 | $2,762 | 27 | Abbott Laboratories ($2,400) |
All Payment Transactions
190 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $65.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/18/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $10.68 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/05/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/22/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $104.17 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/18/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Not Applicable | ||||||
| 10/08/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Heart Failure | ||||||
| 09/19/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Genetic Disease | ||||||
| 09/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $100.45 | General |
| Category: Cardiology | ||||||
| 09/11/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $62.93 | General |
| Category: NEUROLOGY | ||||||
| 08/29/2024 | Daxor Corporation | BVA-100 (Device) | Food and Beverage | Cash or cash equivalent | $109.89 | General |
| Category: Diagnostic Test | ||||||
| 08/29/2024 | Daxor Corporation | BVA-100 (Device) | Food and Beverage | Cash or cash equivalent | $109.89 | General |
| Category: Diagnostic Test | ||||||
| 08/28/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $19.95 | General |
| Category: Coronary | ||||||
| 07/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $71.64 | General |
| Category: Cardio-pulmonary | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $110.74 | General |
| 06/13/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/23/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 05/13/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $84.99 | General |
| Category: Cardiology | ||||||
| 05/10/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 05/09/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 05/08/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Cardiology | ||||||
| 04/11/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $124.89 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 04/01/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $143.13 | General |
| Category: Heart Failure | ||||||
| 02/16/2024 | United Therapeutics Corporation | ORENITRAM (Drug), TYVASO, REMODULIN | Food and Beverage | In-kind items and services | $84.49 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 12/28/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $9.83 | General |
| Category: Heart Failure | ||||||
| 12/14/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,554 | 2,380 | $1.6M | $111,125 |
| 2022 | 26 | 1,228 | 1,914 | $1.0M | $91,253 |
| 2021 | 30 | 1,389 | 2,432 | $1.4M | $117,166 |
| 2020 | 34 | 1,798 | 2,979 | $1.7M | $135,506 |
Total Patients
5,969
Total Services
9,705
Medicare Billing
$455,049
Procedure Codes
123
All Medicare Procedures & Services
123 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 232 | 276 | $86,729 | $24,384 | 28.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 176 | 180 | $590,435 | $22,203 | 3.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 382 | 385 | $457,025 | $20,089 | 4.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 69 | 75 | $32,631 | $10,128 | 31.0% |
| Q9956 | Injection, octafluoropropane microspheres, per ml | Office | 2023 | 64 | 203 | $23,104 | $6,002 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $26,165 | $5,329 | 20.4% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 29 | 500 | $7,256 | $3,898 | 53.7% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 58 | 104 | $29,128 | $2,649 | 9.1% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 29 | 29 | $68,162 | $2,594 | 3.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 28 | 30 | $55,050 | $2,470 | 4.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 27 | $9,224 | $2,368 | 25.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $10,915 | $2,261 | 20.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 75 | 170 | $5,786 | $1,428 | 24.7% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 13 | 13 | $20,708 | $884.60 | 4.3% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 37 | 37 | $17,013 | $744.51 | 4.4% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Facility | 2023 | 23 | 24 | $6,240 | $703.20 | 11.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 37 | 37 | $8,562 | $559.30 | 6.5% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 28 | 29 | $16,266 | $557.96 | 3.4% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 19 | 19 | $26,381 | $515.88 | 2.0% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 27 | 29 | $16,454 | $399.62 | 2.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 26 | 27 | $4,242 | $248.40 | 5.9% |
| 80047 | Blood test, basic group of blood chemicals (calcium, ionized) | Office | 2023 | 12 | 12 | $1,296 | $161.52 | 12.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $3,282 | $143.00 | 4.4% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 23 | 23 | $2,723 | $109.15 | 4.0% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 41 | 44 | $8,257 | $106.92 | 1.3% |
About Dr. Mark Hoffmann, MD
Dr. Mark Hoffmann, MD is a Cardiovascular Disease healthcare provider based in Wausau, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1356342034.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Hoffmann, MD has received a total of $56,629 in payments from pharmaceutical and medical device companies, with $1,557 received in 2024. These payments were reported across 190 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($39,136).
As a Medicare-enrolled provider, Hoffmann has provided services to 5,969 Medicare beneficiaries, totaling 9,705 services with total Medicare billing of $455,049. Data is available for 4 years (2020–2023), covering 123 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Wausau, WI
- Active Since 08/03/2005
- Last Updated 10/21/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1356342034
Products in Payments
- Adempas (Drug) $17,335
- ORENITRAM (Drug) $12,278
- REMODULIN (Drug) $6,620
- Mitra Clip system (Device) $4,101
- TYVASO (Drug) $3,028
- FFRct (Device) $1,701
- Barostim Neo System (Device) $632.78
- UPTRAVI (Drug) $574.36
- JARDIANCE (Drug) $532.27
- ENTRESTO (Drug) $375.00
- OPSUMIT (Drug) $322.81
- CARDIOMEMS (Device) $300.29
- FARXIGA (Drug) $249.97
- Repatha (Biological) $225.45
- BVA-100 (Device) $219.78
- CoreValve Evolut (Device) $178.54
- Arcalyst (Drug) $151.41
- OPSUMIT MACITENTAN (Drug) $147.47
- INJECTAFER (Drug) $135.34
- Kerendia (Drug) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Wausau
Dr. David Murdock, Md, MD
Cardiovascular Disease — Payments: $244,313
Cardiovascular Disease $244,313
Ronnie Ortiz, Md, MD
Cardiovascular Disease — Payments: $33,551
Cardiovascular Disease $33,551
Dr. Daniel Krause, Do, DO
Cardiovascular Disease — Payments: $3,351
Cardiovascular Disease $3,351
Dr. Samer Jabbour, Md, MD
Cardiovascular Disease — Payments: $1,137
Cardiovascular Disease $1,137
Dr. Paul Luetmer, Md, MD
Cardiovascular Disease — Payments: $926.48
Cardiovascular Disease $926.48
Dr. Timothy Logemann, Md, MD
Cardiovascular Disease — Payments: $870.68
Cardiovascular Disease $870.68